Carole L. Nüchterlein

Chief Executive Officer at Roche Ventures

Carole L. Nüchterlein

Carole L. Nüchterlein

Chief Executive Officer at Roche Ventures

Overview
Career Highlights

SangStat Medical Corp.
Roche Ventures

RelSci Relationships

896

Number of Boards

21

Birthday

1961

Age

59

Relationships
RelSci Relationships are individuals Carole L. Nüchterlein likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Roche Holding AG

Relationship likelihood: Strong

Co-Founder, President & Chief Executive Officer at Millendo Therapeutics US, Inc.

Relationship likelihood: Strong

Head, Media Relations at Roche Holding AG

Relationship likelihood: Strong

Co-Founder at Lysosomal Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Lysosomal Therapeutics, Inc.

Relationship likelihood: Strong

Managing Director at Dolby Family Ventures

Relationship likelihood: Strong

Relationship likelihood: Strong

Head-Group Human Resources at Roche Holding AG

Relationship likelihood: Strong

Managing Partner at Avoro Capital Advisor LLC

Relationship likelihood: Strong

Member of the Enlarged Corporate Executive Committee, Global Head Pharma Partnering at Roche Holding AG

Relationship likelihood: Strong

Paths to Carole L. Nüchterlein
Potential Connections via
Relationship Science
You
Carole L. Nüchterlein
Chief Executive Officer at Roche Ventures
Education
JD Unknown

The University of Michigan (UM, U-M, UMich, or U of M), frequently referred to as simply Michigan, is a public research university located in Ann Arbor, Michigan, United States. It is the state's oldest university and the flagship campus of the University of Michigan. It is one of the original eight Public Ivy universities and is one of the founding members of the Association of American Universities. It has been ranked among the top five research universities in the US, and among the top 20 universities in the world. U-M also has satellite campuses in Flint and Dearborn.

BA

A COMMUNITY OF LEARNING DEDICATED TO EXCELLENCE & GROUNDED IN THE LUTHERAN TRADITION OF SCHOLARSHIP, FAITH, & FREEDOM, PREPARING STUDENTS TO LEAD & SERVE IN THE CHURCH & SOCIETY.

JD

The University of Michigan, founded in 1817, celebrates a long and distinguished history. It was in 1787 that the Northwest Territorial Ordinance provided public land for this and other Midwestern universities and established a tradition of respect for excellence in higher education. Three Native American nations—the Ojibwa (Chippewa), Odawa (Ottawa), and Bodewadini (Potawatomi)—subsequently granted certain lands for use of the University of Michigan and by the end of the 19th century, Michigan was the largest and most generously supported public university in America and already a leader in graduate education. The University of Michigan Law School, one of the oldest law schools in the nation, was founded in 1859. But unlike other highly selective law schools established in that era, admission was never restricted to the privileged. When Gabriel Hargo graduated from the Law School in 1870, Michigan—then the largest law school in the country—became the second American university to confer a law degree on an African American. That same year, Michigan was the first major law school to admit a woman, and in 1871, graduate Sarah Killgore became the first woman with a law degree in the nation to be admitted to the bar; by 1890, Michigan had graduated more women than any other law school. That commitment to access and diversity joined an equally powerful commitment to excellence, which continues to this day.

Career History
Chief Executive Officer
2002 - Current

Roche Ventures is an active manager which invests in life science companies. It focuses on series A investments, but also invests at later stages. In general, the firm invests CHF 3-10 million in the first financing round with a 15% ownership stake. It provides follow on financing when needed. The firm's sole investment theme is pharmaceutical innovation leading the prevention, diagnosis and treatment of diseases. The firm takes significant participations in companies with a view to actively support the discovery and development of innovative technologies and medicines, eventually leading to market release with a time horizon of up to several years. Exchange listing may be involved. Portfolio companies include early stage biotech and diagnostics companies.

Deputy Director & Head-Roche Venture Fund
2002 - Current

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Head, Investment
2001 - Current

Roche Venture Fund seeks investments in innovative technology oriented companies with the focus on biotechnology and medicine.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$10K +
2016

The University of Michigan (UM, U-M, UMich, or U of M), frequently referred to as simply Michigan, is a public research university located in Ann Arbor, Michigan, United States. It is the state's oldest university and the flagship campus of the University of Michigan. It is one of the original eight Public Ivy universities and is one of the founding members of the Association of American Universities. It has been ranked among the top five research universities in the US, and among the top 20 universities in the world. U-M also has satellite campuses in Flint and Dearborn.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Carole L. Nüchterlein. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Carole L. Nüchterlein's profile does not indicate a business or promotional relationship of any kind between RelSci and Carole L. Nüchterlein.